🇺🇸 FDA
Patent

US 10537528

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

granted A61KA61K31/145A61K45/06

Quick answer

US patent 10537528 (Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds) held by The Regents of the University of California expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/145, A61K45/06, A61K9/28, A61K9/2806